In addition, c-Met was highly expressed in RCC, and this expression was associated with significantly worse pathological features and overall survival, suggesting that overexpression of c-Met was a potential poor prognostic marker for RCC patients[17–19]. Here, MET is linked to renal cell carcinoma.